PFE vs PIPR · P/E 20, rev $15.03B vs P/E 26, rev $971.4M
Pfizer Inc (PFE) versus Piper Sandler Companies (PIPR) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Piper Sandler Companies (PIPR) is a capital markets company listed on US.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported PIPR revenue for 2026-06-30 was $971.4M. Net income was $133.1M. PIPR currently screens at market cap $4.82B and trailing P/E 25.6.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. PIPR currently screens at market cap $4.82B and trailing P/E 25.6.
Not investment advice. Open the PFE and PIPR stock pages for the full models.
Not investment advice.